expert reviews

Review of: C.A., Siegel M.A., Elting L.S. Lancet Oncol 2006;7(6): 508–514.Although bisphosphonates have been used clinically for more than 30 years, complete knowledge of their pharmacokinetics and pharmacodynamics has not yet...

Review of: Denham J.W, Steigler A., Lamb D.S., Joseph D., Mameghan H., Turner S., Matthews J., Franklin I., Atkinson C., North J., Poulsen M., Christie D., Spry N.A., Tai K.H., Wynne C., Duchesne G., Kovacev O., D’Este C. Lancet...

Review of: Malik A., Afaq F., Sarfaraz S., Adhami V.M., Syed D.N. and Mukhtar H. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14813-14818.What’s new in chemoprevention of prostate cancer using natural dietary...

Review of: Brooks JP, Albert PS, O’Connell J, McLeod DG, Poggi MM. Cancer 2006;106(7):1521-1526.Lymphovascular invasion (LVI) is found on standard hematoxylin and eosin staining and defined as the unequivocal presence of tumour...

The authors conclude that delayed prostate cancer surgery for patients with small, lower-grade prostate cancers does not appear to compromise curability and they point to two important outcomes from the present study

the results presented by this collaborative group may be of utmost interest since it seems like xenotropic LuLV-related viruses can produce an authentic human infection, and strongly implicate RNase L activity in the prevention...

Although this study indicates a role of vitamin E supplementation in male smokers and ß-carotene supplementation in men with low dietary ß-carotene intakes

Review of: Darras J, Joniau S, Van Poppel H. Eur J Surg Oncol. 2006 Jun 29; [Epub ahead of print]Salvage radical prostatectomy has previously been considered to be a major challenge even for welltrained surgeons. However, it may...

In the last decade, a multitude of different risk factors for development of prostate cancer has been studied extensively, including obesity, height, weight, body mass index, physical activity, dietary factors, in particular...

This is the largest randomized multicentre trial so far that shows a significant improvement in freedom of failure in prostate cancer patients treated with a higher dose of radiotherapy